Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

Oral VRL offers easier administration, better quality of life, and cost saving. This study aimed to evaluate the treatment efficacy in terms of tumor response of the two formulations of vinorelbine (VRL, oral and IV) in combination with epirubicin (EPI); and the effect of EPI co-administration on VR...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Chemother Pharmacol
Hlavní autoři: Huang, Liang, Wang, Xiaojia, Zhou, Liheng, Di, Lijun, Zheng, Hongyu, Jiang, Zefei, Wang, Yongsheng, Song, Xiangqun, Feng, Jifeng, Yu, Shiying, Liu, Yunpeng, Zheng, Hong, Shen, Kunwei, Tong, Zhongsheng, Shao, Zhimin
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://ncbi.nlm.nih.gov/pubmed/31838561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-04000-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky